Viramune - 0597-0046-41 - (nevirapine)

Alphabetical Index


Drug Information of Viramune

Product NDC: 0597-0046
Proprietary Name: Viramune
Non Proprietary Name: nevirapine
Active Ingredient(s): 200    mg/1 & nbsp;   nevirapine
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Viramune

Product NDC: 0597-0046
Labeler Name: Boehringer Ingelheim Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020636
Marketing Category: NDA
Start Marketing Date: 20010801

Package Information of Viramune

Package NDC: 0597-0046-41
Package Description: 1 BLISTER PACK in 1 CARTON (0597-0046-41) > 14 TABLET in 1 BLISTER PACK

NDC Information of Viramune

NDC Code 0597-0046-41
Proprietary Name Viramune
Package Description 1 BLISTER PACK in 1 CARTON (0597-0046-41) > 14 TABLET in 1 BLISTER PACK
Product NDC 0597-0046
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name nevirapine
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20010801
Marketing Category Name NDA
Labeler Name Boehringer Ingelheim Pharmaceuticals Inc.
Substance Name NEVIRAPINE
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of Viramune


General Information